Mostrando 7 resultados de: 7
Área temáticas
Enfermedades(7)
Cirugía y especialidades médicas afines(1)
Farmacología y terapéutica(1)
Origen
scopus(7)
Clinical, histopathologic, and immunoarchitectural features of dermatopathic lymphadenopathy: an update
ArticleAbstract: Dermatopathic lymphadenopathy is a distinctive form of paracortical lymph node hyperplasia that usuaPalabras claves:Autores:Castellano-Sánchez A., Garces J.C., Khoury J.D., Li S., Medeiros L.J., Medina A.M., Miranda R.N., Patel K.P., Poppiti R.J., Sofía A. Garcés, Sriganeshan V., Thakral B., Xu J., Yin C.C.Fuentes:scopusCyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal–regulated kinase pathway activation
ArticleAbstract: Activating mutations in the mitogen-activated protein kinase/extracellular signal–regulated kinase (Palabras claves:BCL-2, Cyclin D1, Ki-67, MAPK/ERK, p-ERK, pathogenesis, Rosai-dorfman diseaseAutores:Bhattacharjee M.B., Coelho Siqueira S.A., Cuglievan B., Garces J.C., Jelloul F.Z., Khoury J.D., Li S., Marques-Piubelli M.L., Medeiros L.J., Medina A.M., Miranda R.N., Saluja K., Sofía A. Garcés, Sriganeshan V., Thakral B., Xu J., Yin C.C.Fuentes:scopusFocal Rosai–Dorfman disease coexisting with lymphoma in the same anatomic site: a localized histiocytic proliferation associated with MAPK/ERK pathway activation
ArticleAbstract: Rosai–Dorfman disease is a rare histiocytic disorder shown to have gene mutations that activate thePalabras claves:Autores:González S., Johnson M.R., Khoury J.D., Li S., Manning J.T., Medeiros L.J., Molgó M., Patel K.P., Pina-Oviedo S., Ruiz-Cordero R., Sofía A. Garcés, Xu J., Yin C.C.Fuentes:scopusMutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai-Dorfman disease
ArticleAbstract: Rosai-Dorfman disease is a histiocytic disorder with a poorly defined pathogenesis. Recent molecularPalabras claves:Autores:Garces J.C., Khoury J.D., Li J., Li S., Medeiros L.J., Patel K.P., Pina-Oviedo S., Sofía A. Garcés, Yin C.C.Fuentes:scopusNon-coding NOTCH1 mutations in chronic lymphocytic leukemia negatively impact prognosis
OtherAbstract:Palabras claves:Autores:Bassett R.L., Floyd K., Jain N., Jelloul F.Z., Kanagal-Shamanna R., Loghavi S., Luthra R., Medeiros L.J., Ok C.Y., Patel K.P., Routbort M.J., Sofía A. Garcés, Thompson P.A., Wang P., Wierda W.G., Yang R.K., Yin C.C., Zuo Z.Fuentes:scopusLandscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemia
ArticleAbstract: NOTCH1 is one of the most frequently mutated genes in chronic lymphocytic leukemia and has emerged aPalabras claves:Chronic lymphocytic leukemia, Coding, Non-coding, NOTCH1 mutationsAutores:Bassett R.L., Floyd K., Jain N., Jelloul F.Z., Kanagal-Shamanna R., Loghavi S., Luthra R., Medeiros L.J., Ok C.Y., Patel K.P., Routbort M.J., Sofía A. Garcés, Thompson P.A., Wierda W.G., Yang R.K., Yin C.C., Zuo Z.Fuentes:scopusMantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall
ArticleAbstract: Mantle cell lymphoma (MCL) is a mature B-cell neoplasm characterized by t(11;14) (q13;q32) and cycliPalabras claves:CD200, Chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), Flow cytometry, Immunophenotypic variant, Mantle cell lymphomaAutores:Khanlari M., Li S., Lin P., Medeiros L.J., Ok C.Y., Qiu L., Sofía A. Garcés, Tang G., Vega F., Wang S.A., Xu J., Yin C.C.Fuentes:scopus